Parmax Pharma Ltd - Stock Price

As on13 Aug 2020
  • NSE :
  • BSE : 540359
  • ISIN CODE : INE240T01014
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Parmax Pharma Ltd is not traded on BSE/NSE
+1.56 %+0.5

Balance Sheet

Parameter MAR 19  MAR 18  YoY %Change
Share Capital44.5144.510.00
    Equity - Authorised60.0060.000.00
    Equity - Issued51.0151.010.00
    Equity Paid Up37.4137.410.00
    Equity Shares Forfeited7.107.100.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value10.0010.000.00
Share Warrants & Outstandings0.000.000.00
Total Reserves1.841.0574.62
    Securities Premium0.000.000.00
    Capital Reserves0.000.000.00
    Profit & Loss Account Balance1.841.0574.62
    General Reserves0.000.000.00
    Other Reserves0.000.000.00
Reserve excluding Revaluation Reserve1.841.0574.62
Revaluation reserve0.000.000.00
Shareholder's Funds46.3545.571.73
Minority Interest0.000.000.00
Long-Term Borrowings0.000.000.00
Secured Loans36.760.2018443.56
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks39.180.000.00
    Term Loans - Institutions0.000.000.00
    Other Secured-2.420.20-1321.55
Unsecured Loans15.8319.40-18.38
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.
    Loans - Others15.8313.8014.74
    Other Unsecured Loan0.005.60-100.00
Deferred Tax Assets / Liabilities-0.79-0.24-232.64
    Deferred Tax Assets0.790.24232.64
    Deferred Tax Liability0.000.000.00
Other Long Term Liabilities0.000.000.00
Long Term Trade Payables0.000.000.00
Long Term Provisions0.000.000.00
Total Non-Current Liabilities51.8019.36167.55
Current LiabilitiesNANANA
Trade Payables91.8696.48-4.80
    Sundry Creditors91.8696.48-4.80
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities3.242.1352.01
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers0.000.000.00
    Interest Accrued But Not Due0.000.000.00
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities3.242.1352.01
Short Term Borrowings0.000.000.00
    Secured ST Loans repayable on Demands0.000.000.00
    Working Capital Loans- Sec0.000.000.00
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans0.000.000.00
Short Term Provisions3.062.4823.15
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax1.170.26343.84
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions1.892.22-15.06
Total Current Liabilities98.15101.10-2.91
Total Liabilities196.30166.0218.24
Gross Block70.4269.561.23
Less: Accumulated Depreciation21.2410.9494.19
Less: Impairment of Assets0.000.000.00
Net Block49.1858.63-16.12
Lease Adjustment A/c0.000.000.00
Capital Work in Progress33.290.000.00
Non Current Investments2.010.0133333.33
Long Term Investment2.010.0133333.33
Long Term Loans & Advances1.690.78116.06
Other Non Current Assets0.000.000.00
Total Non-Current Assets86.1659.4145.02
Current Assets Loans & AdvancesNANANA
Currents Investments0.000.000.00
    Raw Materials14.6812.5117.32
    Work-in Progress23.876.35276.12
    Finished Goods0.3512.75-97.26
    Packing Materials0.000.000.00
    Stores  and Spare0.800.5739.99
    Other Inventory0.000.000.00
Sundry Debtors11.4619.72-41.89
    Debtors more than Six months0.002.13-99.97
    Debtors Others11.4617.59-34.84
Cash and Bank15.679.5863.67
    Cash in hand0.320.2817.27
    Balances at Bank15.359.3065.04
    Other cash and bank balances0.000.000.00
Other Current Assets0.000.000.00
    Interest accrued on Investments0.000.000.00
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans0.000.000.00
    Prepaid Expenses0.000.000.00
    Other current_assets0.000.000.00
Short Term Loans and Advances23.5129.64-20.71
    Advances recoverable in cash or in kind23.5129.64-20.71
    Advance income tax and TDS0.000.000.00
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances0.000.000.00
Total Current Assets90.3491.12-0.86
Net Current Assets (Including Current Investments)-7.82-9.9821.67
Miscellaneous Expenses not written off19.8115.4927.85
Total Assets196.30166.0218.24
Contingent Liabilities0.000.000.00
Total Debt55.2821.62155.63
Book Value5.206.14-15.35
Adjusted Book Value5.206.14-15.35

About Parmax Pharma Ltd.

Parmax Pharma Ltd. was incorporated in the year 1994. Its today's share price is 32. Its current market capitalisation stands at Rs 12.16 Cr. In the latest quarter, company has reported Gross Sales of Rs. 120.13 Cr and Total Income of Rs.120.43 Cr. The company's management includes Ami R Shah, Pramay A Chhatra, Asha Satish Daftary, Vipul M Gopani, Umang A Gosalia, Alkesh R Gosalia, Alkesh M Gopani.

It is listed on the BSE with a BSE Code of 540359 , NSE with an NSE Symbol of and ISIN of INE240T01014. It's Registered office is at Plot No. 20, Survey No. 52,8 B - Rajkot - Gondal National Highway No 27,Hadamtala, Tal. Kotda SanganiRajkot-360311, Gujarat. Their Registrars are ACC Ltd. It's auditors are BA Shah Associates, BA Shah SR Mehta & Co

Latest News